Clinical Trial Search Results

407 studies were found about ( lamivudine OR Epivir )
Filter Results: All Studies Studies seeking new volunteers Studies with results

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial

Condition: HIV Infection; Pregnancy; Breastfeeding; HIV Infections

NCT ID: NCT00936195

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

Condition: Disease Transmission, Vertical; Vertical Human Immunodeficiency Virus Transmission; HIV Infections

NCT ID: NCT00099359

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002369

The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002379

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002168

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00074581

Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)

Condition: HIV; Tuberculosis

NCT ID: NCT00851630

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00100048

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001083

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00004852

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Condition: HIV Infections; Human Immunodeficiency Virus

NCT ID: NCT00300573

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00044577

A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002367

The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs

Condition: HIV Infections

NCT ID: NCT00002391

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002389

A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000944

The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection

Condition: HIV Infections

NCT ID: NCT00002179

A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002410

A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002400

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002451

Once-Daily Drug Regimen for HIV-Infected Patients

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00001968

Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV Infection

Condition: HIV Infections

NCT ID: NCT00006443

A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001094

A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002401

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00004999

A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00005106

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Condition: HIV Infections

NCT ID: NCT00004583

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Condition: HIV Infection; HIV Infections

NCT ID: NCT00943540

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00966160

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00011895

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

Condition: HIV Infections

NCT ID: NCT00000903

Steady State PK in Malnourished HIV Infected Children

Condition: HIV Positive; Malnourished

NCT ID: NCT01818258

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00440947

A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

Condition: HIV Infections; AIDS-Associated Nephropathy

NCT ID: NCT00002397

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00004585

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00051090

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00046176

Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002234

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00006441

Study on the Antiviral Therapy and Immune Reconstitution of Chinese HIV/AIDS Patients

Condition: Acquired Immune Deficiency Syndrome; HIV Infections

NCT ID: NCT00872417

The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT

Condition: HIV Infections

NCT ID: NCT00002436

Part A: Drug Interaction Study of GS-7977 and Antiretroviral Therapy(ART) Combinations in Human Immunodeficiency Virus and Hepatitis C Virus (HIV/HCV) Co-infected Patients. Part B: Phase 2, Open-Label Study to Investigate Efficacy and Safety of GS-7977 for 12 Weeks in HIV/HCV Co-infected Patients.

Condition: Hepatitis C; HIV

NCT ID: NCT01565889

Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals

Condition: HIV Infections

NCT ID: NCT00001080

A Study of Two Anti-HIV Drug Combinations

Condition: HIV Infections

NCT ID: NCT00002203

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

Condition: HIV Infections; Chronic Hepatitis B

NCT ID: NCT00023153

A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.

Condition: HIV Infections

NCT ID: NCT00002199

A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002195

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

Condition: HIV Infections

NCT ID: NCT00158821

A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001085

A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00002190

Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00006617

The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001075

A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000887

A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002442

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

Condition: HIV Infections

NCT ID: NCT00002371

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000888

Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment

Condition: HIV Infections

NCT ID: NCT00005017

A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

Condition: HIV Infections

NCT ID: NCT00000841

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Condition: HIV Infection

NCT ID: NCT00244712

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00549198

A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00000896

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Condition: HIV Infections

NCT ID: NCT00002409

A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC

Condition: HIV Infections

NCT ID: NCT00002155

3TC or No 3TC for HIV With 3TC Resistance

Condition: HIV Infections

NCT ID: NCT00143728

A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001084

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00004855

Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00662545

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Condition: HIV Infections

NCT ID: NCT00121979

A Study to Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Condition: HIV Infections

NCT ID: NCT00002423

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding

Condition: HIV Infections

NCT ID: NCT00640263

A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding

Condition: HIV Infections

NCT ID: NCT00146380

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00000919

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00740064

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients

Condition: HBV Coinfection; HIV Infections

NCT ID: NCT01318096

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

Condition: HIV Infection

NCT ID: NCT00038506

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00000901

A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00005764

Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily

Condition: HIV Infections

NCT ID: NCT00002241

A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000878

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

Condition: HIV Infections

NCT ID: NCT00002184

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

Condition: HIV Infections

NCT ID: NCT00612898

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Condition: HIV Infections

NCT ID: NCT00000940

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Condition: HIV Infections

NCT ID: NCT00126880

Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000920

Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)

Condition: HIV Infections

NCT ID: NCT00004981

Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00000872

A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children

Condition: HIV Infections

NCT ID: NCT00001066

A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations

Condition: HIV Infections

NCT ID: NCT00002430

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00038220

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Condition: HIV Infections; Dyslipidemias; Glucose Metabolism Disorders; Metabolic Diseases; Lipodystrophy; Cardiovascular Disease

NCT ID: NCT00192621

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116415

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116116

The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001067

A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past

Condition: HIV Infections

NCT ID: NCT00002320

Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age

Condition: HIV Infections

NCT ID: NCT01127204

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Condition: HIV Infections

NCT ID: NCT00014937

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Condition: HIV Infections

NCT ID: NCT00000885

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01641809

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Condition: HIV Infection; HIV Infections

NCT ID: NCT00865475

Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV

Condition: HIV Infections

NCT ID: NCT00256828

A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002227

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00004578

A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002245

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Condition: HIV Infections

NCT ID: NCT00013520

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Condition: HIV Infections

NCT ID: NCT00424814

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients

Condition: Chronic Infection With HIV

NCT ID: NCT01829802

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

Condition: HIV Infections

NCT ID: NCT00002416

Antiretroviral Therapy for Advanced HIV Disease in South Africa

Condition: HIV

NCT ID: NCT00342355

A Study of a Combination of Four Drugs in Patients With Recent HIV Infection

Condition: HIV Infections

NCT ID: NCT00002233

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Condition: HIV Infections

NCT ID: NCT00323544

A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood

Condition: HIV Infections

NCT ID: NCT00000916

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00307151

A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

Condition: HIV Infection

NCT ID: NCT00053638

Bioequivalence Study of Pediatric Formulations to Treat HIV Infection

Condition: HIV; AIDS

NCT ID: NCT01469520

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

Condition: HIV-1 Infection

NCT ID: NCT00915655

Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00112047

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00008554

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

Condition: HIV Infections

NCT ID: NCT00100568

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002411

A Study of Viracept in HIV-Positive Women

Condition: HIV Infections

NCT ID: NCT00002171

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00033163

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

Condition: HIV Infection

NCT ID: NCT01237444

Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects

Condition: HIV Infections

NCT ID: NCT00350272

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01059422

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children

Condition: HIV Infections

NCT ID: NCT00312091

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand

Condition: HIV Infections

NCT ID: NCT00672412

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China

Condition: HIV Infections

NCT ID: NCT00100594

Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care

Condition: HIV Infections

NCT ID: NCT00028327

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

Condition: HIV Infections

NCT ID: NCT00099632

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment

Condition: HIV Infections

NCT ID: NCT00544128

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00120510

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Condition: HIV Infection

NCT ID: NCT01471821

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00043953

Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers

Condition: HIV Infections

NCT ID: NCT01511237

A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection

Condition: HIV Infections

NCT ID: NCT00002183

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01014481

Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression

Condition: Human Immunodeficiency Virus

NCT ID: NCT01599364

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00084149

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Condition: HIV Infections; AIDS

NCT ID: NCT00122538

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00085943

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Condition: HIV Infection

NCT ID: NCT01159743

Raltegravir Switch for Toxicity or Adverse Events

Condition: HIV/AIDS; Antiretroviral Therapy; HIV Infections

NCT ID: NCT00958100

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT

Condition: HIV; AIDS; Kaposi's Sarcoma; Human Herpesvirus 8

NCT ID: NCT00380770

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

Condition: HIV Infections

NCT ID: NCT00000899

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV-1 Infection

NCT ID: NCT00450580

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents

Condition: Human Immuno Deficiency (HIV) Infections

NCT ID: NCT00799864

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Condition: HIV; Hepatitis B

NCT ID: NCT01125696

Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00004998

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

Condition: HIV-1 Infection

NCT ID: NCT01714414

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Condition: HIV Infections

NCT ID: NCT00084136

Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive

Condition: HIV-1 Infection

NCT ID: NCT01489046

A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir

Condition: HIV Infections

NCT ID: NCT00001095

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002368

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Condition: HIV-1 Infection

NCT ID: NCT01772940

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women

Condition: Malaria; HIV Infections

NCT ID: NCT00993031

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Condition: HIV Infections

NCT ID: NCT00005002

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

Condition: HIV Infections

NCT ID: NCT00000918

A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Condition: HIV Infections

NCT ID: NCT00000952

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00002378

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00009061

Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

Condition: HIV Infections

NCT ID: NCT00001091

Safety and Efficacy Study of Switching From Epzicom to Truvada

Condition: HIV Infection

NCT ID: NCT00724711

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Condition: HIV Infection

NCT ID: NCT00234923

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00001119

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Condition: HIV Infections

NCT ID: NCT00318123

Pharmacokinetics of Lamivudine at Two Different Doses

Condition: HIV Infections

NCT ID: NCT00985647

Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products

Condition: HIV Infections

NCT ID: NCT00455585

A Phase I Study of Methotrexate for HIV Infection

Condition: HIV Infections

NCT ID: NCT00000834

Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL Trial

Condition: HIV Infections

NCT ID: NCT00643968

Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study

Condition: HIV Infections

NCT ID: NCT00537966

Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

Condition: HIV Infections

NCT ID: NCT01618305

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Condition: Hiv Infection With Antiretroviral Therapy Indication; CD4 Below 350/µL or Below 15%

NCT ID: NCT00199979

PREventing Progression of Adipose Tissue Redistribution

Condition: HIV Infections

NCT ID: NCT00389194

Study of Anti-HIV Therapy Intensification

Condition: HIV Infections

NCT ID: NCT00034086

Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa

Condition: HIV

NCT ID: NCT01088516

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Condition: HIV Infections

NCT ID: NCT00000838

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Condition: HIV Infections; Pregnancy

NCT ID: NCT00017719

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00426296

A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop Lipodystrophy

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00006190

Breastfeeding, Antiretroviral, and Nutrition Study

Condition: HIV Infections

NCT ID: NCT00164736

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00141284

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Condition: HIV Infections

NCT ID: NCT00255840

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+

Condition: HIV Seropositivity

NCT ID: NCT01174914

Controlled Clinical Trial of Antiviral Cytotoxic T Lymphocyte (CTL) Infusion Following Combination Antiretroviral Drug Therapy for Asymptomatic HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00000875

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Condition: HIV Infections; Malaria

NCT ID: NCT00719602

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

Condition: HIV Infections

NCT ID: NCT00118898

Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

Condition: HIV Infections; Central Nervous System Diseases; Dementia

NCT ID: NCT01340950

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Condition: HIV Infections

NCT ID: NCT00000902

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection

Condition: Hiv

NCT ID: NCT01751555

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00822315

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

Condition: Hepatitis B; HIV Infection

NCT ID: NCT00013702

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00617643

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

Condition: HIV

NCT ID: NCT01620944

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Condition: HIV Infections

NCT ID: NCT00002124

Pharmacokinetic Study Of EPZICOM Tablet

Condition: HIV Infection

NCT ID: NCT00337922

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00075231

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Condition: HIV Infections

NCT ID: NCT00158405

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Condition: HIV Infections

NCT ID: NCT00006578

Once Daily 3TC, Efavirenz and ddI for HIV Infection

Condition: HIV Infection; AIDS

NCT ID: NCT00214435

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Condition: HIV Infection

NCT ID: NCT00001644

A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00951015

A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy

Condition: HIV Infections

NCT ID: NCT00344760

Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00005918

Switch From Combivir or Trizivir to Truvada - Mitochondrial Effects

Condition: HIV

NCT ID: NCT00960622

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Condition: HIV Infections

NCT ID: NCT00385645

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Condition: HIV Infections

NCT ID: NCT00000882

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01102972

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01231555

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Condition: HIV

NCT ID: NCT01275625

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

Condition: HIV Infections

NCT ID: NCT00002208

A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine

Condition: HIV Infections

NCT ID: NCT00013897

A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine

Condition: HIV Infections

NCT ID: NCT00002424

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

Condition: HIV Infections

NCT ID: NCT00100646

PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00162643

A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01499199

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries

Condition: HIV Infections

NCT ID: NCT01061151

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

Condition: HIV Infections

NCT ID: NCT01160120

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

Condition: HIV Disease

NCT ID: NCT01338025

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Condition: HIV Infection

NCT ID: NCT01307488

The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens

Condition: HIV Infections

NCT ID: NCT00152061

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily

Condition: HIV Infections

NCT ID: NCT00314626

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01263015

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy

Condition: HiV1- Positive

NCT ID: NCT01608269

Atazanavir and Lamivudine for Treatment Simplification

Condition: HIV Infections

NCT ID: NCT00885482

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

Condition: HIV Infections

NCT ID: NCT00192634

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

Condition: HIV Infection

NCT ID: NCT00094367

Abacavir and Lamivudine PK in Children

Condition: HIV

NCT ID: NCT01656122

A Study of Disease Progression and Anti-HIV Treatments

Condition: HIV Infections

NCT ID: NCT00001068

Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir

Condition: HIV Infections

NCT ID: NCT01294761

Zidovudine and Lamivudine Given Once Versus Twice Daily

Condition: HIV Infections

NCT ID: NCT00014014

Durability of Nevirapine-Based Antiretroviral Regimen

Condition: HIV Infections

NCT ID: NCT00703898

Study of Once Daily Elvucitabine Versus Lamivudine in Subjects With a Documented M184V Mutation

Condition: HIV Infections

NCT ID: NCT00312039

Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)

Condition: HIV Infections; AIDS

NCT ID: NCT00116298

A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP

Condition: HIV Infections

NCT ID: NCT00669487

Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients

Condition: HIV Infections

NCT ID: NCT00084253

Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment

Condition: Tuberculosis; Human Immunodeficiency Virus Infections

NCT ID: NCT00332306

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)

Condition: HIV

NCT ID: NCT01253538

Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection

Condition: AIDS/HIV PROBLEM

NCT ID: NCT01844310

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

Condition: HIV Infections; Liver Toxicity; Hepatitis Co-infection

NCT ID: NCT01273142

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Condition: HIV Infection

NCT ID: NCT00326716

3TC (Lamivudine; GR109714X) Open-Label Program

Condition: HIV Infections

NCT ID: NCT00002108

A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART

Condition: HIV Infections

NCT ID: NCT00000874

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00002216

Triomune Bioequivalence With Innovators

Condition: HIV/AIDS

NCT ID: NCT01025830

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine

Condition: HIV-1

NCT ID: NCT00098293

The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002376

Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects

Condition: Birth Defects; Infection, Human Immunodeficiency Virus

NCT ID: NCT01137981

Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Condition: HIV Infections

NCT ID: NCT00002429

MARCH Central Nervous System Substudy

Condition: HIV-1 Infection

NCT ID: NCT01637233

Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With HIV Infection and Modestly Detectable Viral Load.

Condition: HIV Infections

NCT ID: NCT00040157

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

Condition: HIV Infections

NCT ID: NCT00618176

Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)

Condition: HIV Infections

NCT ID: NCT00346567

Sex, Aging and Antiretroviral Pharmacokinetics

Condition: HIV Infections

NCT ID: NCT00666055

Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada

Condition: HIV-1

NCT ID: NCT00324649

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

Condition: HIV Infections

NCT ID: NCT00627055

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Condition: HIV Infections

NCT ID: NCT00001108

Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa

Condition: Cryptococcal Meningitis; HIV Infections

NCT ID: NCT00830856

Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00005000

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Condition: HIV Infections; Hemophilia A

NCT ID: NCT00002386

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00000922

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00004736

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Condition: HIV Infections

NCT ID: NCT00000865

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Condition: HIV Infections

NCT ID: NCT00120783

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00078247

Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics

Condition: HIV

NCT ID: NCT01386970

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Condition: HIV Infections

NCT ID: NCT00050895

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

Condition: HIV Infections

NCT ID: NCT00135382

2NN & CHARM Long-Term Follow-up Study

Condition: HIV Infections

NCT ID: NCT00127972

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Condition: HIV Infections

NCT ID: NCT00000891

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Condition: HIV Infections

NCT ID: NCT00000870

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002407

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00091936

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Condition: Malaria; HIV Infections

NCT ID: NCT00978068

Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC

Condition: HIV Infections

NCT ID: NCT00338390

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001087

FREE Study: Efficacy and Toxicity of Trizivir

Condition: HIV Infections

NCT ID: NCT00405925

Genotype Based Personalized Prescription of Nevirapine

Condition: Nevirapine Induced Rash; Nevirapine Induced Hepatitis; HIV; Adverse Side Effects; AIDS; HIV Infections

NCT ID: NCT00986063

Strategies for Delivering Anti-HIV Therapy in South Africa

Condition: HIV Infections

NCT ID: NCT00080522

A Prospective Cohort of Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00476606

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00122226

Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy

Condition: AIDS Dementia Complex; HIV Infections

NCT ID: NCT00002209

A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive

Condition: HIV Infections

NCT ID: NCT00002215

NRTI-Sparing Pilot Study

Condition: HIV; Mitochondrial Toxicity

NCT ID: NCT00143689

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

Condition: HIV Infections

NCT ID: NCT00000831

A Study of Combivir Plus Abacavir Plus 141W94 in Patients Who Previously Have Used Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002217

Trial to Evaluate Efficacy and Safety of Nevirapine 150mg/m2 Versus 4-7mg/kg With 3TC and ZDV for Pediatric Patients

Condition: HIV Infections

NCT ID: NCT00273975

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

Condition: HIV Infections

NCT ID: NCT00385957

Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen

Condition: HIV Infections

NCT ID: NCT00135369

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Condition: HIV Infections

NCT ID: NCT00000923

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial

Condition: HIV-1

NCT ID: NCT00772902

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

Condition: HIV Infection

NCT ID: NCT00158470

Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00144157

Study of Options for Second-Line Effective Combination Therapy (SELECT)

Condition: HIV-1 Infection

NCT ID: NCT01352715

Blood Levels of Abacavir in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00087945

The Adult Antiretroviral Treatment and Resistance Study (Tshepo)

Condition: AIDS; HIV Infection

NCT ID: NCT00197613

Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00483054

Increasing HAART-Induced Immune Restoration With Cyclosporine

Condition: HIV Infections

NCT ID: NCT00031070

Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy

Condition: AIDS/HIV PROBLEM

NCT ID: NCT01844297

A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01597648

ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial

Condition: HIV Infections

NCT ID: NCT00615810

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

Dose Reduction of Lopinavir in Children

Condition: HIV Infections

NCT ID: NCT00887120

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Condition: HIV

NCT ID: NCT00335270

The Mochudi Prevention Project ART Protocol

Condition: HIV Infections

NCT ID: NCT01583439

A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001086

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01449929

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

Condition: Fracture; Infection, Human Immunodeficiency Virus

NCT ID: NCT01077557

Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00876733

Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV

Condition: Kwashiorkor; Marasmus; Severe Acute Malnutrition; HIV

NCT ID: NCT01529125

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00820118

A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00001443

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

Condition: HIV Infections

NCT ID: NCT00164762

Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00021463

Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir

Condition: HIV Infections

NCT ID: NCT00214890

A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00002162

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01227824

Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT01366547

Evaluation of the Bioequivalence of a Combined Formulated Tablet

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01622790

Mechanisms of Lipodystrophy in HIV-Infected Pateints

Condition: HIV Infections

NCT ID: NCT00457665

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Condition: HIV Infections

NCT ID: NCT00043888

MARCH Renal Substudy

Condition: Proteinuria; HIV

NCT ID: NCT01637259

Safety Study of Elvucitabine in HIV-1 Subjects

Condition: HIV Infections

NCT ID: NCT00405249

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Condition: HIV-1

NCT ID: NCT01192035

ARVs to Prevent Breastmilk HIV:Viral and Immune Responses

Condition: HIV Infections

NCT ID: NCT00167674

To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir

Condition: HIV

NCT ID: NCT00335192

A Study of Single Dose NVP With 4 or 7 Day Course of Combivir for pMTCT - Treatment Options Preservation Study (TOPS)

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00144183

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection With the Objective to Induce a Strong Specific HIV Immune Response Able to Control Viral Replication Without Highly Active Anti-Retroviral Therapy (HAART)

Condition: HIV

NCT ID: NCT00979706

Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients

Condition: HIV; Zidovudine Adverse Reaction

NCT ID: NCT01540240

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Condition: HIV Infections; Hepatitis B; Hepatitis C

NCT ID: NCT00051077

Response to Standard HIV Treatment in Bamako, Mali

Condition: HIV Infections

NCT ID: NCT00703404

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

Condition: HIV Infection

NCT ID: NCT00280969

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Condition: HIV Infections; HIV-1

NCT ID: NCT00543725

Phase 1 Pilot Study of an ART Bridging Regimen in Highly Experienced Patients Unable to Achieve Viral Suppression

Condition: HIV Infections

NCT ID: NCT00336778

Switch to Unboosted Atazanavir With Tenofovir Study

Condition: HIV Infection

NCT ID: NCT01351740

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

Condition: NVP Plasma Level; NVP Related Mutation; 3TC Related Mutation

NCT ID: NCT00872872

A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Condition: HIV Infections

NCT ID: NCT00029341

Artery Elasticity After Switch From Epzicom to Truvada

Condition: HIV Infections

NCT ID: NCT00998582

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Condition: HIV Infections

NCT ID: NCT00491556

HIV Treatment and CVD Events

Condition: HIV Infection; Cardiovascular Disease; Infection, Human Immunodeficiency Virus; Acute Myocardial Infarction

NCT ID: NCT01054638

Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine

Condition: HIV+

NCT ID: NCT01813292

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Condition: HIV

NCT ID: NCT01255371

Safety and Effectiveness of a Combination Anti-HIV Drug Treatment

Condition: HIV Infections

NCT ID: NCT00005018

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00050908

A Long Term, Safety Study of Apricitabine in HIV-infected Subjects

Condition: HIV Infection

NCT ID: NCT00367952

Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

Condition: HIV Infections

NCT ID: NCT00312169

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

Condition: HIV; Impaired Cognition

NCT ID: NCT01367236

Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV

Condition: HIV Transmission; HIV Infections

NCT ID: NCT00949234

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

Condition: HIV Infection

NCT ID: NCT00246610

Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients

Condition: Mitochondrial Toxicity; Metabolic Complications

NCT ID: NCT01601899

The Effect of Phenytoin on the Pharmacokinetics of Nevirapine and the Development of Nevirapine Resistance

Condition: HIV-infection; Pregnancy; Mother to Child Transmission

NCT ID: NCT01187719

A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00727597

Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

Condition: Hepatitis B

NCT ID: NCT00051038

Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral Therapy

Condition: HIV

NCT ID: NCT01694017

Molecular Diversity of HIV-1 Group O Strains and Treatment Management in Cameroon

Condition: HIV Infections

NCT ID: NCT00658346

A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure

Condition: HIV-1 Infection

NCT ID: NCT01641367

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

Condition: HIV; Pregnancy

NCT ID: NCT01854762

Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)

Condition: Tuberculosis; Aids; Hiv Infections

NCT ID: NCT00495326

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)

Condition: HIV Infections

NCT ID: NCT01159223

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

Virological and Clinical Anti-Hepatitis B Virus (HBV) Efficacy of Tenofovir and Emtricitabine in Patients With HIV/HBV co-Infection

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00127959

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Condition: Human Immunodeficiency Virus (HIV) Infections; Acquired Immunodeficiency Syndrome (AIDS) Virus

NCT ID: NCT01448707

Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.

Condition: AIDS

NCT ID: NCT01344148

Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

Condition: HIV Infections

NCT ID: NCT00753324

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

Condition: HIV/TB Co-infection

NCT ID: NCT01805258

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir

Condition: HIV Infections

NCT ID: NCT01031849

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Condition: HIV Infections

NCT ID: NCT00144105

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Condition: HIV Infection

NCT ID: NCT01576731

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Condition: HIV Infection

NCT ID: NCT01533272

Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

Condition: Hepatitis B; HIV Infections

NCT ID: NCT00391638

Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

Condition: HIV Infection

NCT ID: NCT00009256

The Effect of Hyperbilirubinemia on CV Disease, Neurocog Function and Renal Function

Condition: HIV

NCT ID: NCT01475240

Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis

Condition: HIV; Tuberculosis

NCT ID: NCT01635153

NOW Thai HAART Study

Condition: HIV; AIDS; Neurological Complications

NCT ID: NCT00367731

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00978237

Drug Exposure Registry for GSK2248761, an Investigational NNRTI

Condition: Seizures; Infection, Human Immunodeficiency Virus

NCT ID: NCT01458132

When to Start HIV Treatment in Previously Untreated HIV/TB Coinfected Individuals

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01300481

Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders

Condition: HIV

NCT ID: NCT01817283

A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection

Condition: Hepatitis B Virus

NCT ID: NCT00476411

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

Ritonavir-boosted Lopinavir Monotherapy

Condition: HIV

NCT ID: NCT01002898

Telaprevir Open-Label Study in Co-Infected Patients

Condition: Hepatitis C, Chronic

NCT ID: NCT01500616

A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00398996

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Condition: HIV Infections

NCT ID: NCT00621166

GW873140 In Combination With Combivir In HIV Infected Subjects

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00104429

Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis

Condition: HIV Infections; Tuberculous Meningitis

NCT ID: NCT00433719

An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01776996

A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV

Condition: HIV Infection

NCT ID: NCT00082394

Long Term Treatment Interruptions

Condition: HIV Infections; AIDS

NCT ID: NCT00433056

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Condition: AIDS

NCT ID: NCT00207168

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Condition: AIDS-Related Kaposi's Sarcoma

NCT ID: NCT00834457

Antiretroviral Drug Levels During and After Pregnancy

Condition: Pharmacokinetics

NCT ID: NCT00616252

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects

Condition: Healthy Volunteers

NCT ID: NCT01220232